(Q48113208)

8 February 2018

title

DTI and PWI analysis of peri-enhancing tumoral brain tissue in patients treated for glioblastoma (English)

1 reference

8 February 2018

1 reference

Alessandro Stecco

1

1 reference

8 February 2018

Carla Pisani

2

1 reference

8 February 2018

Raffaella Quarta

3

1 reference

8 February 2018

Marco Brambilla

4

1 reference

8 February 2018

Laura Masini

5

1 reference

8 February 2018

Debora Beldì

6

1 reference

8 February 2018

Sara Zizzari

7

1 reference

8 February 2018

Rita Fossaceca

8

1 reference

8 February 2018

Marco Krengli

9

1 reference

8 February 2018

Alessandro Carriero

10

1 reference

8 February 2018

publication date

25 July 2010

1 reference

8 February 2018

Journal of Neuro-Oncology

published in

1 reference

8 February 2018

volume

102

1 reference

8 February 2018

issue

2

1 reference

8 February 2018

page(s)

261-271

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1007/s11060-010-0310-x

exact match

0 references

cites work

Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Role of diffusion- and perfusion-weighted MR imaging for brain tumour characterisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Redefinition of multiple sclerosis plaque size using diffusion tensor MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Cerebral perfusion in infants and neonates: preliminary results obtained using dynamic susceptibility contrast enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Diffusion tensor imaging in primary brain tumors: reproducible quantitative analysis of corpus callosum infiltration and contralateral involvement using a probabilistic mixture model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Diffusion-Tensor MR Imaging of Intracranial Neoplasia and Associated Peritumoral Edema: Introduction of the Tumor Infiltration Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0310-X

Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors.

21 January 2018

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

The role of diffusion-weighted imaging in patients with brain tumors.

1 reference

12 December 2020

Diffusion tensor MR imaging of high-grade cerebral gliomas

1 reference

12 December 2020

10.1007/S11060-010-0310-X

Identifiers

DOI

1 reference

8 February 2018

1 reference

8 February 2018